Alpha Tau Medical (DRTS) Enterprise Value (2020 - 2026)
Alpha Tau Medical (DRTS) reported Enterprise Value of -$76.4 million for Q1 2026, down 48.0% on a YoY basis from -$146.9 million in Q1 2025, and down 4.5% sequentially from -$73.1 million in Q4 2025.
Alpha Tau Medical (DRTS) Enterprise Value (2020 - 2026) Analysis & Trends
Alpha Tau Medical (DRTS) has 7 years of Enterprise Value data on file, last reported at -$76.4 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 48.0% year-over-year to -$76.4 million; the trailing twelve-month figure through Mar 2026 stood at -$76.4 million (down 48.0% YoY), and the FY2025 full-year result was -$73.1 million, down 22.69% from the prior year.
- Enterprise Value fell to -$76.4 million in Q1 2026, from -$73.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$51.6 million in Q1 2025 to a low of -$8.2 billion in Q1 2022.
- A 5-year average of -$559.1 million and a median of -$79.7 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value sank 68881.88% in 2022 and soared 98.78% in 2023, its largest moves.
- Tracing DRTS's Enterprise Value over 5 years: stood at -$104.5 million in 2022, then increased by 21.76% to -$81.8 million in 2023, then advanced by 27.13% to -$59.6 million in 2024, then declined by 22.69% to -$73.1 million in 2025, then retreated by 4.5% to -$76.4 million in 2026.
- Business Quant data shows DRTS's Enterprise Value at -$76.4 million in Q1 2026, -$73.1 million in Q4 2025, and -$72.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Alpha Tau Medical | 1.12 Bn | 1.04 Bn | - | -76.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.42 Mn |
| Dec 31, 2025 | -73.13 Mn |
| Sep 30, 2025 | -72.21 Mn |
| Jun 30, 2025 | -79.70 Mn |
| Mar 31, 2025 | -51.64 Mn |
| Dec 31, 2024 | -59.60 Mn |
| Sep 30, 2024 | -65.22 Mn |
| Jun 30, 2024 | -71.03 Mn |
| Mar 31, 2024 | -77.55 Mn |
| Dec 31, 2023 | -81.79 Mn |
| Sep 30, 2023 | -87.22 Mn |
| Jun 30, 2023 | -94.36 Mn |
| Mar 31, 2023 | -99.65 Mn |
| Dec 31, 2022 | -104.53 Mn |
| Sep 30, 2022 | -107.67 Mn |
| Jun 30, 2022 | -112.83 Mn |
| Mar 31, 2022 | -8.19 Bn |
| Dec 31, 2021 | -31.32 Mn |
| Mar 31, 2021 | -11.87 Mn |
| Dec 31, 2020 | -46.02 Mn |